"Influenza A virus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The type species of the genus INFLUENZAVIRUS A that causes influenza and other diseases in humans and animals. Antigenic variation occurs frequently between strains, allowing classification into subtypes and variants. Transmission is usually by aerosol (human and most non-aquatic hosts) or waterborne (ducks). Infected birds shed the virus in their saliva, nasal secretions, and feces.
Descriptor ID |
D009980
|
MeSH Number(s) |
B04.820.545.405.400
|
Concept/Terms |
Influenza A virus- Influenza A virus
- Influenza A viruses
- Influenza Viruses Type A
- Orthomyxovirus Type A
Orthomyxovirus Type A, Avian- Orthomyxovirus Type A, Avian
- Pestis galli Myxovirus
- Myxovirus, Pestis galli
- Myxoviruses, Pestis galli
- Pestis galli Myxoviruses
- Avian Orthomyxovirus Type A
- Fowl Plague Virus
- Fowl Plague Viruses
- Plague Virus, Fowl
- Plague Viruses, Fowl
- Virus, Fowl Plague
- Viruses, Fowl Plague
- Myxovirus pestis galli
|
Below are MeSH descriptors whose meaning is more general than "Influenza A virus".
Below are MeSH descriptors whose meaning is more specific than "Influenza A virus".
- Influenza A virus
- Influenza A Virus, H10N7 Subtype
- Influenza A Virus, H10N8 Subtype
- Influenza A Virus, H1N1 Subtype
- Influenza A Virus, H1N2 Subtype
- Influenza A Virus, H2N2 Subtype
- Influenza A Virus, H3N2 Subtype
- Influenza A Virus, H3N8 Subtype
- Influenza A Virus, H5N1 Subtype
- Influenza A Virus, H5N2 Subtype
- Influenza A Virus, H5N8 Subtype
- Influenza A Virus, H7N1 Subtype
- Influenza A Virus, H7N2 Subtype
- Influenza A Virus, H7N3 Subtype
- Influenza A Virus, H7N7 Subtype
- Influenza A Virus, H7N9 Subtype
- Influenza A Virus, H9N2 Subtype
This graph shows the total number of publications written about "Influenza A virus" by people in this website by year, and whether "Influenza A virus" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 3 | 0 | 3 |
1996 | 4 | 0 | 4 |
1997 | 0 | 1 | 1 |
1998 | 1 | 2 | 3 |
1999 | 3 | 0 | 3 |
2000 | 4 | 0 | 4 |
2002 | 1 | 0 | 1 |
2003 | 3 | 0 | 3 |
2004 | 4 | 2 | 6 |
2005 | 1 | 0 | 1 |
2006 | 4 | 0 | 4 |
2008 | 1 | 0 | 1 |
2009 | 0 | 4 | 4 |
2010 | 2 | 1 | 3 |
2012 | 3 | 2 | 5 |
2013 | 2 | 1 | 3 |
2014 | 2 | 0 | 2 |
2015 | 1 | 1 | 2 |
2016 | 1 | 5 | 6 |
2017 | 2 | 1 | 3 |
2018 | 1 | 0 | 1 |
2019 | 9 | 3 | 12 |
2020 | 3 | 0 | 3 |
2021 | 1 | 0 | 1 |
2022 | 3 | 0 | 3 |
2023 | 1 | 0 | 1 |
2024 | 2 | 1 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Influenza A virus" by people in Profiles.
-
Vaccine Effectiveness Against Influenza A-Associated Hospitalization, Organ Failure, and Death: United States, 2022-2023. Clin Infect Dis. 2024 Apr 10; 78(4):1056-1064.
-
Necroptosis blockade prevents lung injury in severe influenza. Nature. 2024 Apr; 628(8009):835-843.
-
Neutrophil-derived Activin-A moderates their pro-NETotic activity and attenuates collateral tissue damage caused by Influenza A virus infection. Front Immunol. 2024; 15:1302489.
-
Lack of neutralizing antibodies against influenza A viruses in adults during the 2022/2023 winter season - a serological study using retrospective samples collected in Hong Kong. Int J Infect Dis. 2023 Oct; 135:1-4.
-
Profiling of innate and adaptive immune cells during influenza virus infection reveals sex bias in invariant natural killer T (iNKT) cells. Immun Inflamm Dis. 2023 04; 11(4):e837.
-
Temporal control of protein labeling by a photo-caged benzaldehyde motif and discovery of host cell factors of avian influenza virus infection. Chem Commun (Camb). 2022 Aug 18; 58(67):9345-9348.
-
Spatial Metabolomics Reveals Localized Impact of Influenza Virus Infection on the Lung Tissue Metabolome. mSystems. 2022 08 30; 7(4):e0035322.
-
Interim Estimates of 2021-22 Seasonal Influenza Vaccine Effectiveness - United States, February 2022. MMWR Morb Mortal Wkly Rep. 2022 Mar 11; 71(10):365-370.
-
Redirecting host preexisting influenza A virus immunity for cancer immunotherapy. Cancer Immunol Immunother. 2022 Jul; 71(7):1611-1623.
-
False positive Influenza rapid tests using newly EUA cleared multiplex assay in a low prevalence setting. J Med Virol. 2021 06; 93(6):3285.